Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Heart Transplantation

  Free Subscription

Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 84 articles:
HTML format

Single Articles

    December 2022
    Commentary: Collateral impact of the HVAD decision and the path forward.
    J Thorac Cardiovasc Surg. 2022;164:1942-1943.

  2. JAWAD K, Sipahi F, Koziarz A, Huhn S, et al
    Less-invasive ventricular assist device implantation: A multicenter study.
    J Thorac Cardiovasc Surg. 2022;164:1910-1918.
    PubMed     Abstract available

    September 2022
  3. TANG PC, Haft JW, Lei I, Wang Z, et al
    Impact of donor blood type on outcomes after prolonged allograft ischemic times.
    J Thorac Cardiovasc Surg. 2022;164:981-993.
    PubMed     Abstract available

    August 2022
  4. EAPEN S, Nordan T, Critsinelis AC, Li B, et al
    Blood type O heart transplant candidates have longer waitlist time and higher delisting under the new allocation system.
    J Thorac Cardiovasc Surg. 2022 Aug 8. pii: S0022-5223(22)00826.
    PubMed     Abstract available

    July 2022
  5. SHAH AS
    Normothermic regional perfusion in donor heart recovery: Establishing a new normal.
    J Thorac Cardiovasc Surg. 2022;164:142-146.

  6. TCHOUTA L, Drake D, Hoenerhoff M, Rojas-Pena A, et al
    Twenty-four-hour normothermic perfusion of isolated ex vivo hearts using plasma exchange.
    J Thorac Cardiovasc Surg. 2022;164:128-138.
    PubMed     Abstract available

    Commentary: Plasma exchange during extended normothermic ex vivo perfusion of donor hearts may lead to the Holy Grail of nonemergency transplantation!
    J Thorac Cardiovasc Surg. 2022;164:139-140.

    June 2022
  8. SHAFII A, Liao K, Ghanta RK
    Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall.
    J Thorac Cardiovasc Surg. 2022;163:2129-2130.

    May 2022
  9. WELLS DA, Morales DLS
    Commentary: Set me free-cell-free DNA may soon provide reprieve to pediatric heart transplant recipients.
    J Thorac Cardiovasc Surg. 2022 May 28. pii: S0022-5223(22)00610.

  10. CHEN Q, Emerson D, Megna D, Osho A, et al
    Heart transplantation using donation after circulatory death in the United States.
    J Thorac Cardiovasc Surg. 2022 May 15. pii: S0022-5223(22)00533.
    PubMed     Abstract available

  11. ROACH A, Trento A, Peiris A, Kobashigawa J, et al
    Trainee experience on ischemic times and outcomes following orthotopic heart transplantation.
    J Thorac Cardiovasc Surg. 2022 May 14. pii: S0022-5223(22)00604.
    PubMed     Abstract available

  12. LI SS, Osho A, Moonsamy P, D'Alessandro DA, et al
    Trends in the use of hepatitis C viremic donor hearts.
    J Thorac Cardiovasc Surg. 2022;163:1873-1885.
    PubMed     Abstract available

    April 2022
  13. KAWABORI M, Critsinelis AC, Patel S, Nordan T, et al
    Total ventricular mass oversizing +50% or greater was a predictor of worse 1-year survival after heart transplantation.
    J Thorac Cardiovasc Surg. 2022 Apr 30. pii: S0022-5223(22)00505.
    PubMed     Abstract available

  14. MAH KE, Morales DLS
    Commentary: The Vulcan mind MELD-XI.
    J Thorac Cardiovasc Surg. 2022;163:1477-1478.

    Commentary: The dilemma of donor heart cold storage: Are stem cell extracellular vesicles the answer?
    J Thorac Cardiovasc Surg. 2022;163:e294-e295.

  16. WANG M, Yan L, Li Q, Yang Y, et al
    Mesenchymal stem cell secretions improve donor heart function following ex vivo cold storage.
    J Thorac Cardiovasc Surg. 2022;163:e277-e292.
    PubMed     Abstract available

    March 2022
  17. DANI A, Price N, Thangappan K, Ryan TD, et al
    Heart-kidney listing is better than isolated heart listing for pediatric heart transplant candidates with significant renal insufficiency.
    J Thorac Cardiovasc Surg. 2022 Mar 1. pii: S0022-5223(22)00221.
    PubMed     Abstract available

    February 2022
  18. KAKU Y, Takeda K, Naka Y
    Commentary: The role of mechanical circulatory support in heart retransplantation.
    J Thorac Cardiovasc Surg. 2022;163:723-724.

  19. HAN JJ, Smood B, Atluri P
    Commentary: Vita nova or vanitas? Outcomes in cardiac retransplantation.
    J Thorac Cardiovasc Surg. 2022;163:721-722.

  20. ZHU Y, Shudo Y, Lingala B, Baiocchi M, et al
    Outcomes after heart retransplantation: A 50-year single-center experience.
    J Thorac Cardiovasc Surg. 2022;163:712-720.
    PubMed     Abstract available

    Commentary: Heat shock protein 90 inhibition and donor heart protection-a paradoxical concept?
    J Thorac Cardiovasc Surg. 2022;163:e201-e202.

  22. ACEROS H, Der Sarkissian S, Borie M, Pinto Ribeiro RV, et al
    Novel heat shock protein 90 inhibitor improves cardiac recovery in a rodent model of donation after circulatory death.
    J Thorac Cardiovasc Surg. 2022;163:e187-e197.
    PubMed     Abstract available

    January 2022
  23. KANG L, Markert ML, Turek JW
    Induction of donor-specific tolerance to heart transplantation: From concept to clinical translation.
    J Thorac Cardiovasc Surg. 2022 Jan 14. pii: S0022-5223(22)00028.

  24. WOODS RK, Kirklin JK, Maeda K, Adachi I, et al
    We need better pediatric cardiac transplantation risk modeling.
    J Thorac Cardiovasc Surg. 2022 Jan 11. pii: S0022-5223(22)00016.

    Commentary: Being at the table, not on the menu: Surgeon-initiated call for better risk stratification of pediatric heart transplant recipients.
    J Thorac Cardiovasc Surg. 2022 Jan 11. pii: S0022-5223(22)00017.

    Commentary: Heart transplantation listing for children with significant renal insufficiency: The need for a paradigm shift.
    J Thorac Cardiovasc Surg. 2022 Jan 8. pii: S0022-5223(22)00006.

  27. POWER A, Jaquiss RDB
    Commentary: Donor-specific tolerance in heart transplantation: A marathon, not a sprint.
    J Thorac Cardiovasc Surg. 2022 Jan 8. pii: S0022-5223(22)00011.

    Commentary: Chicken or egg: Does risk-adjustment hide the deleterious consequences of bridging to transplant with temporary devices?
    J Thorac Cardiovasc Surg. 2022;163:149-150.

  29. NIKOLOVA A, Youn JC, Kobashigawa JA
    Commentary: The anticlimax of the left ventricular assist devices-associated antibodies.
    J Thorac Cardiovasc Surg. 2022;163:136-137.

  30. IYENGAR A, Smood BF, Atluri P
    Commentary: Fear of rejection: Acute cellular rejection after ventricular assist device placement.
    J Thorac Cardiovasc Surg. 2022;163:135-136.

  31. BAKIR NH, Finnan MJ, MacGregor RM, Schilling JD, et al
    Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;163:124-134.
    PubMed     Abstract available

    December 2021
  32. SADE RM, Carpenter AJ, D'Amico TA, Drake DH, et al
    Unethical studies on transplantation in cardiothoracic surgery journals.
    J Thorac Cardiovasc Surg. 2021;162:1647-1653.

    October 2021
  33. HESS NR, Hickey GW, Sultan I, Kilic A, et al
    Redo orthotopic heart transplantation in the current era.
    J Thorac Cardiovasc Surg. 2021 Oct 30. pii: S0022-5223(21)01506.
    PubMed     Abstract available

    Commentary: Redo heart transplantation: Lessons learned over the past 20 years.
    J Thorac Cardiovasc Surg. 2021 Oct 6. pii: S0022-5223(21)01409.

    September 2021
    Commentary: Bridge to bridge: No longer a bridge too far for successful cardiac transplant.
    J Thorac Cardiovasc Surg. 2021 Sep 29. pii: S0022-5223(21)01393.

  36. NOLY PE, Moriguchi J, Shah KB, Anyanwu AC, et al
    A bridge-to-bridge approach to heart transplantation using extracorporeal membrane oxygenation and total artificial heart.
    J Thorac Cardiovasc Surg. 2021 Sep 20. pii: S0022-5223(21)01364.
    PubMed     Abstract available

  37. SMITH DE, Kon ZN, Carillo JA, Chen S, et al
    Early experience with donation after circulatory death heart transplantation using normothermic regional perfusion in the United States.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01316.
    PubMed     Abstract available

    August 2021
  38. KILIC A
    Commentary: Left ventricular assist device therapy: The time is now.
    J Thorac Cardiovasc Surg. 2021;162:614-615.

  39. SHUDO Y, Maeda K
    Commentary: Accepting only over-sized donors for adult congenital heart disease-Is it being overcautious?
    J Thorac Cardiovasc Surg. 2021;162:429-430.

  40. DESHPANDE S, Alsoufi B
    Meeting needs-pushing boundaries: Mechanical circulatory support in children; year in review.
    J Thorac Cardiovasc Surg. 2021;162:400-404.

  41. LAWRENCE KM, Ittenbach RF, Hunt ML, Kaplinski M, et al
    Attrition between the superior cavopulmonary connection and the Fontan procedure in hypoplastic left heart syndrome.
    J Thorac Cardiovasc Surg. 2021;162:385-393.
    PubMed     Abstract available

  42. PHILIP J, Powers E, Machado D, Colon DL, et al
    Pulsatile ventricular assist device as a bridge to transplant for the early high-risk single-ventricle physiology.
    J Thorac Cardiovasc Surg. 2021;162:405-413.
    PubMed     Abstract available

    June 2021
    Commentary: Extracorporeal membrane oxygenation as a bridge to heart transplantation: Will we revisit Heisenberg's uncertainty principle and the observer effect?
    J Thorac Cardiovasc Surg. 2021 Jun 8. pii: S0022-5223(21)00898.

  44. THOMPSON MP, Likosky DS
    Commentary: Can and should the National Inpatient Sample be used to evaluate trends in ventricular assist device use and outcomes?
    J Thorac Cardiovasc Surg. 2021;161:2093-2094.

  45. SHARMA VJ, Iyengar AJ, Zannino D, Gentles T, et al
    Protein-losing enteropathy and plastic bronchitis after the Fontan procedure.
    J Thorac Cardiovasc Surg. 2021;161:2158-2165.
    PubMed     Abstract available

    May 2021
  46. IVEY-MIRANDA JB, Maulion C, Farrero-Torres M, Griffin M, et al
    Risk stratification of patients listed for heart transplantation while supported with extracorporeal membrane oxygenation.
    J Thorac Cardiovasc Surg. 2021 May 29. pii: S0022-5223(21)00877.
    PubMed     Abstract available

  47. DESHPANDE S, Sparks JD, Alsoufi B
    Pediatric heart transplantation: Year in review 2020.
    J Thorac Cardiovasc Surg. 2021 May 3. pii: S0022-5223(21)00758.

  48. KNOPER RC, John R
    Commentary: The only constant is change: Understanding the changes in the new heart allocation system.
    J Thorac Cardiovasc Surg. 2021;161:1851-1852.

  49. RAO V
    Commentary: The ethics of donor allocation.
    J Thorac Cardiovasc Surg. 2021;161:1849-1851.

  50. LE AT, Mokadam NA
    Commentary: Flying too close to the sun.
    J Thorac Cardiovasc Surg. 2021;161:1848-1849.

  51. ALAM A, Meyer DM, Hall SA
    Commentary: History is prologue: If we fail to learn from our past, we are doomed to repeat it.
    J Thorac Cardiovasc Surg. 2021;161:1847-1848.

    April 2021
  52. CALLAHAN CP, Jegatheeswaran A, Barron DJ, Husain SA, et al
    Factors associated with mortality or transplantation versus Fontan completion after cavopulmonary shunt for patients with tricuspid atresia.
    J Thorac Cardiovasc Surg. 2021 Apr 30. pii: S0022-5223(21)00745.
    PubMed     Abstract available

  53. DARK JH, Mehew J, Venkateswaran R
    Prolongation of time from brain death to retrieval is beneficial to the donor heart.
    J Thorac Cardiovasc Surg. 2021;161:e311-e312.

  54. JAWITZ OK, Raman V
    Reply from authors: Heart donor brain death duration-external validation from across the pond.
    J Thorac Cardiovasc Surg. 2021;161:e313.

  55. LE AT, Mokadam NA
    Reply: Riding out the storm.
    J Thorac Cardiovasc Surg. 2021;161:e312-e313.

  56. RASKIN A, Zafar F, Morales DLS
    Commentary: Is there life after cardiac death? Considering the challenges of heart donation after circulatory death.
    J Thorac Cardiovasc Surg. 2021;161:1344-1345.

  57. KON ZN, Smith DE, Carillo JA, Moazami N, et al
    Commentary: The future is now-heart donation after circulatory death.
    J Thorac Cardiovasc Surg. 2021;161:1342-1343.

    March 2021
  58. GANAPATHI AM, Lampert BC, Mokadam NA, Emani S, et al
    Allocation changes in heart transplantation: What has really changed?
    J Thorac Cardiovasc Surg. 2021 Mar 16. pii: S0022-5223(21)00510.
    PubMed     Abstract available

    Commentary: Selecting the right cardiac donor.
    J Thorac Cardiovasc Surg. 2021;161:1061-1062.

  60. KAWABORI M, Critsinelis AC, Hironaka CE, Chen FY, et al
    Right ventricular undersizing is associated with increased 1-year mortality.
    J Thorac Cardiovasc Surg. 2021;161:1048-1059.
    PubMed     Abstract available

    February 2021
  61. WOODS RK
    Commentary: The Fontan cardiac transplant-Time to embrace change.
    J Thorac Cardiovasc Surg. 2021 Feb 23. pii: S0022-5223(21)00367.

  62. AMDANI S, Simpson KE, Thrush P, Shih R, et al
    Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
    J Thorac Cardiovasc Surg. 2021 Feb 18. pii: S0022-5223(21)00262.
    PubMed     Abstract available

  63. OVERBEY DM, Lodge AJ
    Commentary: Neonatal heart transplant: A good option in a bad situation.
    J Thorac Cardiovasc Surg. 2021 Feb 12. pii: S0022-5223(21)00260.

  64. MELEHY A, Sanchez JE, Nemeth SK, Kurlansky PA, et al
    National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00213.
    PubMed     Abstract available

    Commentary: The importance and treachery of patient selection for neonatal heart transplant.
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00240.

  66. IUS F, Moscalenco D, Boethig D, Tudorache I, et al
    Cardiac valve operations after solid organ transplantation: A single-center experience.
    J Thorac Cardiovasc Surg. 2021;161:595-606.
    PubMed     Abstract available

    January 2021
    Commentary: Neonatal heart transplant: Conservation status-critically endangered.
    J Thorac Cardiovasc Surg. 2021 Jan 30. pii: S0022-5223(21)00197.

  68. LIN Y, Davis TJ, Zorrilla-Vaca A, Wojcik BM, et al
    Neonatal heart transplant outcomes: A single institutional experience.
    J Thorac Cardiovasc Surg. 2021 Jan 23. pii: S0022-5223(21)00130.
    PubMed     Abstract available

  69. GUARIENTO A, Blitzer D, Vida V
    Commentary: Donor selection in heart transplantation: It's a match!
    J Thorac Cardiovasc Surg. 2021 Jan 19. pii: S0022-5223(21)00107.

    December 2020
  70. MONDAL NK, Ghanta RK
    Commentary: Getting better with every beat. Extending the clock with ex vivo perfusion for heart transplantation.
    J Thorac Cardiovasc Surg. 2020 Dec 25. pii: S0022-5223(20)33422.

  71. WITER L, Kilic A
    Commentary: Proceed with caution: Right ventricular undersizing in heart transplant.
    J Thorac Cardiovasc Surg. 2020 Dec 13. pii: S0022-5223(20)33358.

    November 2020
  72. RIGGS KW, Morales DLS, Zafar F
    Commentary: Is two ever better than one in pediatric ventricular assist device support? The controversy continues.
    J Thorac Cardiovasc Surg. 2020;160:1309-1310.

  73. DYKES JC, Maeda K
    Commentary: To BiVAD or not to BiVAD...that is the question?
    J Thorac Cardiovasc Surg. 2020;160:1310-1311.

    October 2020
  74. AHMED H, Anderson JB, Bates KE, Fleishman CE, et al
    Development of a validated risk score for interstage death or transplant after stage I palliation for single-ventricle heart disease.
    J Thorac Cardiovasc Surg. 2020;160:1021-1030.
    PubMed     Abstract available

    September 2020
  75. IBRAHIM M, Kilic A
    Commentary: Heart transplantation using hepatitis C-positive donors: What are we waiting for?
    J Thorac Cardiovasc Surg. 2020 Sep 18. pii: S0022-5223(20)32652.

    Commentary: Moving forward, looking back: Lessons from coronavirus disease 2019 (COVID-19) for preparedness in advanced heart failure programs.
    J Thorac Cardiovasc Surg. 2020 Sep 9. pii: S0022-5223(20)32581.

  77. MEHAFFEY JH, Hawkins RB
    Commentary: Building bridges to the future of heart transplantation.
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32559.

    Commentary: From the trenches: Lessons on caring for patients with heart failure during coronavirus disease 2019 (COVID-19).
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32567.

  79. BANSAL A, Goldstein D, Schettle S, Pepitone S, et al
    Institutional preparedness strategies for heart failure, durable left ventricular assist device, and heart transplant patients during the Coronavirus Disease 2019 (COVID-19) pandemic.
    J Thorac Cardiovasc Surg. 2020 Sep 2. pii: S0022-5223(20)32490.

    May 2020
  80. BARTFAY SE, Dellgren G, Hallhagen S, Wahlander H, et al
    Durable circulatory support with a paracorporeal device as an option for pediatric and adult heart failure patients.
    J Thorac Cardiovasc Surg. 2020 May 15. pii: S0022-5223(20)31166.
    PubMed     Abstract available

    February 2020
  81. HAFT JW
    Commentary: Can we finally move the needle in organ donation?
    J Thorac Cardiovasc Surg. 2020;159:514.

  82. IYENGAR A, Atluri P
    Commentary: Keeping your cool: Donor heart preservation using the SherpaPak Cardiac Transport System.
    J Thorac Cardiovasc Surg. 2020;159:e125-e126.

  83. MOAYEDI Y, Gulamhusein AF, Khush KK
    Treading lightly as we step into a new era: Use of hepatitis C virus-infected organs for transplantation.
    J Thorac Cardiovasc Surg. 2020;159:505-510.

  84. NAITO N, Funamoto M, Pierson RN, D'Alessandro DA, et al
    First clinical use of a novel hypothermic storage system for a long-distance donor heart procurement.
    J Thorac Cardiovasc Surg. 2020;159:e121-e123.

Thank you for your interest in scientific medicine.

AMEDEO Heart Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.